Evidence map›Paper›PMID 35202309›Full record

ArticleVeterinary sciences2022

Molecular Genetic Investigation of Digital Melanoma in Dogs.

David Conrad, Alexandra Kehl, Christoph Beitzinger, Thomas Metzler, Katja Steiger, Nicole Pfarr, Konrad Fischer, Robert Klopfleisch, Heike Aupperle-Lellbach

Abstract read
In one paragraph

Article in Veterinary sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review of Molecular Technologies for Investigating Canine Cancer.Animals : an open access journal from MDPI · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

David ConradDepartment of Pathology, LABOKLIN GmbH & Co. KG, 97688 Bad Kissingen, Germany.
Alexandra KehlDepartment of Molecular Biology, LABOKLIN GmbH & Co. KG, 97688 Bad Kissingen, Germany.ORCID 0000-0002-1547-0713
Christoph BeitzingerDepartment of Molecular Biology, LABOKLIN GmbH & Co. KG, 97688 Bad Kissingen, Germany.
Thomas MetzlerInstitute of Pathology, School of Medicine, Technische Universität München, 81675 München, Germany.
Katja SteigerInstitute of Pathology, School of Medicine, Technische Universität München, 81675 München, Germany.ORCID 0000-0002-7269-5433
Nicole PfarrInstitute of Pathology, School of Medicine, Technische Universität München, 81675 München, Germany.ORCID 0000-0002-5977-5375
Konrad FischerSchool of Life Sciences Weihenstephan, Technische Universität München, 85354 Freising, Germany.
Robert KlopfleischDepartment of Pathology, Freie Universität Berlin, 14163 Berlin, Germany.
Heike Aupperle-LellbachDepartment of Pathology, LABOKLIN GmbH & Co. KG, 97688 Bad Kissingen, Germany.

Funding

Bavarian Research Foundation AZ-1365-18SFB1335 360372040 (project number)SFB1371 395357507 (project number)
6 · The paper itself

Abstract

Canine digital melanoma, in contrast to canine oral melanoma, is still largely unexplored at the molecular genetic level. The aim of this study was to detect mutant genes in digital melanoma. Paraffin-embedded samples from 86 canine digital melanomas were examined for the

Indexed as

acralBRAFcaninec-kitCNVKITLGKRASmutationNRAStumour

Identifiers

PMID35202309
PMCPMC8874500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.